mdlinx mdlinx

Family Medicine - Pain Management News & Articles

MDLinx Family Medicine stands out from other primary care literature review services because of our dedication to keeping our members current in less time. On a daily basis, receive an email with just the ‘headlines’ covering everything important that published in your specialty in the past 24 hours. Or, choose to Focus On the top articles published in the hottest topics in primary care, such as heart failure, depression, diabetes mellitus, eczema/psoriasis, infectious diseases, rheumatoid arthritis, COPD, and many more.

Additional bonus content is also available on this page, including clinical pearls from The Smartest Family Physician, a daily quiz competition from the editors of MDLinx Internal Medicine in collaboration with the Cleveland Clinic Center for Continuing Education. Additionally, enjoy the can’t-miss articles highlighted by our own physician editor, D. Scott Cunningham, MD, PhD.

Your Unread Messages in Family Medicine

See All >> Messages include industry-sponsored communications and special communications from MDLinx
New! >> Find out who is the Smartest Doc in Family Medicine!

Articles

Latest (4) Full Text Articles (157) Focus on Cancer
Ranked, sorted, and summarized by MDLinx editors from the latest literature
Topics:

921 On the generalised embodiment of pain: how interoceptive sensitivity modulates cutaneous pain perception Pain, June 18, 2012

922 Review of the history and current status of cell-transplant approaches for the management of neuropathic pain Full Text Pain Research and Treatment, June 18, 2012

923 Bilateral renal infarction following atrial fibrillation and thromboembolism and presenting as acute abdominal pain: a case report Full Text Journal of Medical Case Reports, June 18, 2012

924 Inter-therapist agreement in classifying patients with cervical radiculopathy and patients with non-specific neck-arm pain Manual Therapy , June 18, 2012

925 Acute pain management and assessment: are guidelines being implemented in developing countries (Lebanon) Journal of Evaluation in Clinical Practice, June 15, 2012

926 Assessment of physical activity by movement registration systems in chronic pain: methodological considerations The Clinical Journal of Pain, June 15, 2012

927 A pilot randomized controlled trial of an oral care intervention to reduce mucositis severity in stem cell transplant patients Journal of Pain and Symptom Management, June 15, 2012

928 Mild interlaminar decompression for the treatment of lumbar spinal stenosis: procedure description and case series with 1-year follow-up The Clinical Journal of Pain, June 15, 2012

929 Parents who catastrophize about their child's pain prioritize attempts to control pain Pain, June 15, 2012

930 Intact 2D-form recognition despite impaired tactile spatial acuity in complex regional pain syndrome type I Pain, June 15, 2012

931 The role of corticosteroids in the treatment of pain in cancer patients Current Pain and Headache Reports, June 14, 2012    Clinical Article

932 Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS) The Journal of Headache and Pain, June 14, 2012

933 Laser heat stimulation of tiny skin areas adds valuable information to quantitative sensory testing in postherpetic neuralgia Pain, June 14, 2012

934 Prevalence, burden, and correlates of physical and psychological symptoms among hiv palliative care patients in sub-saharan africa: an international multicenter study Journal of Pain and Symptom Management, June 14, 2012

935 A successful palliative care intervention for cancer pain refractory to intrathecal analgesia Journal of Pain and Symptom Management, June 14, 2012

936 Evidence of spinal cord hyperexcitability as measured with nociceptive flexion reflex (nfr) threshold in chronic lateral epicondylalgia with or without a positive neurodynamic test The Journal of Pain, June 14, 2012

937 Patients with persistent pain after breast cancer surgery show both delayed and enhanced cortical stimulus processing Full Text Journal of Pain Research, June 14, 2012

938 Treatment of perimenstrual migraine with triptans: an update Current Pain and Headache Reports, June 13, 2012

939 Physiotherapists' knowledge, attitudes, and intolerance of uncertainty influence decision making in low back pain The Clinical Journal of Pain, June 13, 2012

940 Is botulinum toxin a effective for the treatment of plantar fasciitis? The Clinical Journal of Pain, June 13, 2012

50 available pages First Previous 41 42 43 44 45 46 47 48 49 50 Next Last

Clinical Pearls in Family Medicine

Highlights in Family Medicine

Vitamin D supplementation decreases systemic inflammation in T2DM

In a 12-week randomized, controlled trial, ingestion of a vitamin D-fortified yogurt (170 mg calcium + 500 IU vitamin D/250 mL; n=50) twice daily decreased markers of inflammation compared with placebo yogurt (170 mg calcium; n=50). Compared with baseline measures, the 25(OH)D levels were increased and the TNF-alpha, IL-6, hsCRP, SAA, and IL-10 levels were decreased in the group supplemented with vitamin D compared with the group that received placebo.

Read the article summary

Mediterranean diet associated with decreased diabetes, cardiovascular events, and all-cause mortality

Researchers at the University of Palermo conducted a study involving 9109 subjects with a mean follow-up of 6.2 years which showed that the subjects who adhered to a Mediterranean diet had increased dietary fiber, decreased total dietary fat, and an increased intake of monosaturated-to-saturated fats. Further, the incidence of diabetes, cardiovascular events, and all-cause mortality was lower in the subjects who followed a Mediterranean diet.

Read the article summary

Natalizumab superior to IFN-? 1a in MS patients

Based on a retrospective study conducted at the Federico II University (Naples), researchers have concluded that treatment of patients (n=84) with relapsing-remitting MS natalizumab for 12-24 months resulted in a greater reduction in disease activity (annualized relapse rate, .24 vs. .55, respectively) and disability progression than patients treated with INF-? 1a. The number of contrast-enhancing lesions was also less in the natalizumab-treated group.

Read the article summary

Get reports via email to claim your reading activity at MDLinx as Category 2 CME (It takes less than a minute)

Other Topics in Family Medicine

Register now to view all the MDLinx contents (FREE)!

  • Stay current on the latest literature, research and clinical news
  • Get special communications and offers from MDLinx and our sponsors
  • Receive invitations to paid market research
View Samples and Register

Stay current - Media Tool

Newsletter
RSS
Follow Us
Facebook

Receive free subspecialty
"5-minute updates" via email

Sign up!

Send the E-mail Newsletter to a Colleague


Send

Subscribe to our free RSS feeds:
Get the latest news in your specialty automatically added to your newsreader or your personal My Yahoo!, Google, My MSN or My AOL page. Learn More

Follow Us on Twitter
Twitter is a rich source of instantly updated information. Join today and follow @MDLinx to start receiving tweets. Learn More

Close